Long COVID: major findings, mechanisms and recommendations

HE Davis, L McCorkell, JM Vogel… - Nature Reviews …, 2023 - nature.com
Long COVID is an often debilitating illness that occurs in at least 10% of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. More than 200 symptoms …

Long COVID: what is known and what gaps need to be addressed

B Krishna, M Wills, N Sithole - British Medical Bulletin, 2023 - academic.oup.com
Introduction Long COVID is a chronic condition that follows after acute COVID-19 and is
characterized by a wide range of persistent, cyclic symptoms. Sources of data PubMed …

Toward a pan-SARS-CoV-2 vaccine targeting conserved epitopes on spike and non-spike proteins for potent, broad and durable immune responses

CY Wang, WJ Peng, BS Kuo, YH Ho, MS Wang… - PLoS …, 2023 - journals.plos.org
Background The SARS-CoV-2 non-Spike (S) structural protein targets on nucleocapsid (N),
membrane (M) and envelope (E), critical in the host cell interferon response and memory T …

Intra-host evolution analyses in an immunosuppressed patient supports SARS-CoV-2 viral reservoir hypothesis

D Fournelle, F Mostefai, E Brunet-Ratnasingham… - Viruses, 2024 - mdpi.com
Throughout the SARS-CoV-2 pandemic, several variants of concern (VOCs) have been
identified, many of which share recurrent mutations in the spike glycoprotein's receptor …

Comparison of reverse transcription (RT)-quantitative PCR and RT-droplet digital PCR for detection of genomic and subgenomic SARS-CoV-2 RNA

S Morón-López, E Riveira-Muñoz, V Urrea… - Microbiology …, 2023 - Am Soc Microbiol
Most individuals acutely infected with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) exhibit mild symptoms. However, 10 to 20% of those infected develop long …

Considerations in children and adolescents related to coronavirus disease 2019 (COVID-19)

EY Chen, JM Burton, A Johnston… - Physical Medicine …, 2023 - pmr.theclinics.com
Since the start of the Coronavirus Disease 2019 (COVID-19) pandemic, over 14.6 million
pediatric COVID-19 cases have been reported in the United States—about 18.4% of all total …

UB-612 multitope vaccine targeting SARS-CoV-2 spike and non-spike proteins provides broad and durable immune responses

CY Wang, WJ Peng, BS Kuo, H Liu, YH Ho, MS Wang… - medRxiv, 2022 - medrxiv.org
ABSTRACT The SARS-CoV-2 non-Spike (S) structural protein targets of nucleocapsid (N),
membrane (M) and envelope (E), critical in the host cell interferon response and memory T …

Intra-host viral populations of SARS-CoV-2 in immunosuppressed patients with hematologic cancers

D Fournelle, F Mostefai, E Brunet-Ratnasingham… - bioRxiv, 2022 - biorxiv.org
Throughout the SARS-CoV-2 pandemic, several variants of concern (VOC) have been
identified, many of which share recurrent mutations in the spike protein's receptor binding …

[HTML][HTML] Immunology of post-COVID syndrome

SG Sсherbak, AM Sarana, DA Vologzhanin… - Russian …, 2023 - medjrf.com
COVID-19, the disease caused by SARS-CoV-2, has diverse long-term consequences of
varying severity after recovery from the acute phase. As survivorship and therefore the …